BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Veeva Systems Release: Industry Research Shows 97% of Companies to Increase Use of Real-World Patient Data for More Accurate Decision-Making

  November 10, 2017

   · 

  6 min read
• Business

  IP Veteran Andrew Filler Joins BioSig Technologies’ Board of Directors

  Mr. Filler brings to BioSig over 20 years of experience in intellectual property for technology and medical device companies.

  November 10, 2017

   · 

  4 min read
• Notice of Extraordinary General Meeting in Getinge AB

  The shareholders of Getinge are hereby invited to attend the EGM” to be held on Monday, December 4, 2017 at 16.00 CET, at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden.

  November 10, 2017

   · 

  5 min read
• 

  Getinge Sets Revised Strategy, New Financial Targets Ahead of Arjo Listing

  Focus is on organic growth and Getinge foresees an organic market growth of 2-4% on average during 2017-2020 in the addressable market.

  November 10, 2017

   · 

  21 min read
• 

  Business

  Inotrem, Roche Diagnostics Ink Septic Shock R&D Deal

  It is Roche Diagnostics’ first collaboration agreement with a startup biotech company.

  November 10, 2017

   · 

  2 min read
• Biotech Bay

  SentreHEART Announces Participation at American Heart Association Scientific Sessions 2017

  SentreHEART, the manufacturer of the LARIAT Suture Delivery Device (LARIAT) will be participating in the American Heart Association (AHA) Scientific Sessions 2017 in Anaheim, California November 11-15, 2017.

  November 10, 2017

   · 

  2 min read
• Drug Development

  Infinity Pharma Reports IPI-549 Clinical and Translational Data From Completed Monotherapy Dose-Escalation Component of Phase I/Ib Clinical Study in Patients With Advanced Solid Tumors at SITC Annual Meeting

  These data from the recently completed monotherapy dose-escalation component of the Phase I/Ib study demonstrated that IPI-549 dosed once daily (QD) was well tolerated and clinically active.

  November 10, 2017

   · 

  11 min read
• Quotient Sciences Launches as the New Global Identity for Quotient Clinical

  Quotient Clinical announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research.

  November 10, 2017

   · 

  2 min read
• Business

  U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract With Personal Genome Diagnostics

  The contract includes PDGx’s CancerSELECT 125 tissue and PlasmaSELECT64 liquid biopsy profiling panels.

  November 10, 2017

   · 

  2 min read
• Pharm Country

  Bristol-Myers Squibb Release: U.S. Food and Drug Administration Expands Approval of Sprycel (Dasatinib) to Include Treatment of Children With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase

  Bristol-Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel (dasatinib) tablets to include the treatment of children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP).

  November 10, 2017

   · 

  21 min read